About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Orphan Drugs: Research and Reviews
›
top-articles
Orphan Drugs: Research and Reviews
0.6
(top 50%)
impact factor
19
(top 100%)
papers
47
(top 100%)
citations
4
(top 100%)
h
-index
0.6
(top 50%)
impact factor
37
all documents
173
doc citations
7
(top 100%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Prussian blue as an antidote for radioactive thallium and cesium poisoning
Orphan Drugs: Research and Reviews
0
45
2
Nitisinone: a review
Orphan Drugs: Research and Reviews
0
23
3
Post-marketing access to orphan drugs: a critical analysis of health technology assessment and reimbursement decision-making considerations
Orphan Drugs: Research and Reviews
2014
15
4
A 30-year retrospective: National Organization for Rare Disorders, the Orphan Drug Act, and the role of rare disease patient advocacy groups
Orphan Drugs: Research and Reviews
0
13
5
Do ultra-orphan medicinal products warrant ultra-high prices? A review
Orphan Drugs: Research and Reviews
0
9
6
Orphan drugs in glioblastoma multiforme: a review
Orphan Drugs: Research and Reviews
0
6
7
Wilson’s disease: a review of treatment options with a focus on zinc therapy
Orphan Drugs: Research and Reviews
2012
5
8
Stiripentol for the treatment of Dravet syndrome
Orphan Drugs: Research and Reviews
2014
5
9
Drugs in development and dietary approach for Duchenne muscular dystrophy
Orphan Drugs: Research and Reviews
0
5
10
Pompe disease: clinical perspectives
Orphan Drugs: Research and Reviews
0
5
11
Spotlight on anagrelide hydrochloride for the treatment of essential thrombocythemia
Orphan Drugs: Research and Reviews
2017
5
12
Current management options for tyrosinemia
Orphan Drugs: Research and Reviews
0
4
13
Access to cross-border health care services for patients with rare diseases in the European Union
Orphan Drugs: Research and Reviews
2014
4
14
Update on the challenges of treating trigeminal neuralgia
Orphan Drugs: Research and Reviews
0
4
15
Orphan drugs for sickle vaso-occlusion: dawn of a new era of targeted treatment
Orphan Drugs: Research and Reviews
2015
4
16
New treatments in development for Pseudomonas aeruginosa infections in the lungs of individuals with cystic fibrosis
Orphan Drugs: Research and Reviews
2014
3
17
Betaine treatment of cystathionine β-synthase-deficient homocystinuria; does it work and can it be improved?
Orphan Drugs: Research and Reviews
2012
2
18
Optimal management of interstitial lung disease associated with dermatomyositis/polymyositis: lessons from the Japanese experience
Orphan Drugs: Research and Reviews
0
2
19
Orphan drugs in development for urea cycle disorders: current perspectives
Orphan Drugs: Research and Reviews
0
2
20
Angiogenesis inhibitors in gastric cancer
Orphan Drugs: Research and Reviews
2014
2
21
Fahr's disease: current perspectives
Orphan Drugs: Research and Reviews
2015
2
22
Adverse events reported for hereditary angioedema medications: a retrospective study of spontaneous reports submitted to the EudraVigilance database, 2007-2013
Orphan Drugs: Research and Reviews
0
2
23
An update on gene therapy for the treatment of lipoprotein lipase deficiency
Orphan Drugs: Research and Reviews
0
1
24
Profile of aminopyridines for Lambert–Eaton myasthenic syndrome
Orphan Drugs: Research and Reviews
0
1
25
Amyotrophic lateral sclerosis: clinical perspectives
Orphan Drugs: Research and Reviews
2015
1
26
Paroxysmal nocturnal hemoglobinuria: new concepts in pathophysiology and treatment
Orphan Drugs: Research and Reviews
2015
1
27
Orphan drugs for the treatment of aspergillosis: focus on isavuconazole
Orphan Drugs: Research and Reviews
2017
1
28
Medical treatment of rare diseases must be put on the agenda
Orphan Drugs: Research and Reviews
2011
0
29
Potential role of enzastaurin in the treatment of patients with relapsed or refractory advanced cutaneous T-cell lymphomas: a review
Orphan Drugs: Research and Reviews
2012
0
30
Tipifarnib and farnesyltransferase inhibitors in the treatment of inflammatory breast cancer: is the story over? A review
Orphan Drugs: Research and Reviews
0
0
31
Orphan drugs in development for primary biliary cirrhosis: challenges and progress
Orphan Drugs: Research and Reviews
2015
0
32
The efficacy and safety of adalimumab in ocular inflammatory disease
Orphan Drugs: Research and Reviews
2015
0
33
Denosumab in the treatment of hypercalcemia secondary to malignancy
Orphan Drugs: Research and Reviews
2015
0
34
Orphan drugs in development for long-chain fatty acid oxidation disorders: challenges and progress
Orphan Drugs: Research and Reviews
0
0
35
Profile of lumacaftor/ivacaftor combination: potential in the treatment of cystic fibrosis
Orphan Drugs: Research and Reviews
0
0
36
Orphan drugs in development for Huntington's disease: challenges and progress
Orphan Drugs: Research and Reviews
2015
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.